معرفی
Dr. Anneliese Ashhurst is a Research Fellow in the School of Medical Sciences at the University of Sydney, affiliated with the Sydney Infectious Diseases Institute (Sydney ID) and the Charles Perkins Centre. Her research focuses on developing therapies to control inflammation in skin conditions like psoriasis and dermatitis, as well as studying pulmonary immune responses to infectious diseases such as tuberculosis and influenza. She collaborates with interdisciplinary teams in pharmaceutical science and chemistry to advance translational outcomes. Dr. Ashhurst holds memberships in key organizations including the Australia and New Zealand Society of Immunology and GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis). She also contributes to teaching and mentoring, supervising research students and lecturing in undergraduate programs.
Her research interests span innovative vaccine design for respiratory pathogens, immunomodulatory therapies for chronic inflammation, and the development of inhalation-based drug delivery systems. She leads or co-leads grants targeting SARS-CoV-2 vaccines and therapies for skin inflammation, including a project on the peptide RP23 funded by GRAPPA. Dr. Ashhurst is a member of multiple research networks such as the Centre for Translational Skin Research and the Westmead Institute for Medical Research.
